0728EBB37752C9AD872586D3006E8ADA Hearing Summary

Representative Roberts,
bill co-sponsor, introduced SB-094.  The bill continues the State
Board of Pharmacy for nine years, until September 1, 2030.  In addition,
the bill adjusts the types of pharmacists that are included on the board,
aligns state statute with the federal Drug Quality and Security Act, and
modifies the board’s authority to inspect certain facilities. The bill
also includes various changes to the scope of practice for pharmacy professionals
and the regulation of certain medical facilities, as described below.



Scope of practice—pharmacists.  The bill expands the scope of
practice for pharmacists to include providing care pursuant to a collaborative
pharmacy practice agreement; expanding prescriptive authority, including
the administration of opiate antagonists; ordering laboratory tests as
related to medication therapy; and performing limited physical assessments.
 Pharmacists may fill a prescription for a specific drug with a substitute
and make minor adaptations to a prescription, under certain conditions.
 The bill also requires pharmacists to offer patient counseling and
directs the board to adopt rules addressing such services, and expands
the number of designees a pharmacist may authorize to access the Prescription
Drug Monitoring Program.



Scope of practice—pharmacy technicians.  The scope of practice
for pharmacy technicians is also expanded to include documenting nonclinical
information from patients and replenishing automated dispensing devices
without pharmacist verification if using bar code technology.



Facility regulation.  The bill adjusts the regulation of certain
medical facilities by adding community mental health clinics and facilities
that operate a licensed substance use disorder treatment program to the
definition of “other outlets,” and requiring 503B outsourcing facilities
and third-party logistics providers to register with the board.



Other changes.  The bill makes a variety of other changes, including:




·        repealing the requirement that the board justify
to the Veterinary Pharmaceutical Advisory Committee any deviations from
the committee’s recommendations;

·        repeals the ability of prescription drug outlets
to register as compounding drug outlets;

·        increasing the amount of medication a hospital
is authorized to dispense from a 24-hour supply to a 72-hour supply, and
permits hospitals to dispense prescription drugs to a patient for a temporary
leave from the hospital of less than 72 hours;

·        repealing the requirement that a prescription
for an anabolic steroid require its purpose be printed on the label; and


·        requiring the board to adopt rules for electronic
records storage.

The bill sponsor responded to questions from the committee.

Dr. Gina Moore, University of Colorado, testified in support of the bill. Dr. Emily Zadvorny, Colorado Pharmacist Society, testified in support of the bill. The witnesses responded to questions from the committee.

Dr. Tara Vlasimsky, SCL Health, testified in support of the bill. Mr. Ky Davis, RxPlus Pharmacies, testified in support of the bill. Mr. Tom Davis, RxPlus Pharmacies, testified in support of the bill. Mr. Chris Gassen, Department of Regulatory Agencies, answered questions from the committee.

The committee took a brief recess.

The bill sponsors provided closing comments on the bill.

The committee members made closing comments on the bill.